本页面由Tiger Trade Technology Pte. Ltd.提供服务

Forte BioSciences Inc

32.49
+2.839.54%
成交量:24.64万
成交额:784.83万
市值:4.07亿
市盈率:-7.40
高:33.00
开:29.46
低:29.25
收:29.66
52周最高:33.00
52周最低:4.90
股本:1,252.69万
流通股本:926.19万
量比:1.32
换手率:2.66%
股息:- -
股息率:- -
每股收益(TTM):-4.3909
每股收益(LYR):-12.1671
净资产收益率:-110.72%
总资产收益率:-58.07%
市净率:4.84
市盈率(LYR):-2.67

数据加载中...

2022/09/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/12

重要事件披露

8-K - Current report
2022/08/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/08/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/12

重要事件披露

8-K - Current report
2022/07/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/06/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/06/07

重要事件披露

8-K - Current report
2022/06/02

重要事件披露

8-K - Current report
2022/05/24

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/16

重要事件披露

8-K - Current report